SCHEMBL28673552

SCHEMBL28673552

O=S(=O)(OCC(F)C(F)F)C(F)(F)F

nearest known ligand 0.34

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CA2 P00918 2/20 0.34
CA1 P00915 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL145453 0.81 CA2 (0.36) CA2CA1
SCHEMBL3521831 0.81 CA2 (0.36) CA2CA1
SCHEMBL16115817 0.77 CA2 (0.34) CA2CA1
SCHEMBL19713240 0.76 CA2 (0.33) CA2CA1
SCHEMBL780303 0.74 CA2 (0.35) CA2CA1
SCHEMBL271903 0.74 CA2 (0.35) CA2CA1
SCHEMBL14779158 0.74 CA2 (0.50) CA2CA1
SCHEMBL18762503 0.74 CA2 (0.35) CA2CA1
SCHEMBL20267825 0.74 CA2 (0.35) CA2CA1
SCHEMBL7421600 0.72 CA2 (0.32) CA2CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113816969-B Eptification control compound, antibody drug conjugate thereof and application thereof 联宁(苏州)生物制药有限公司 2024-01-16 CN disclosed
CN-113816969-A Irinotecan compound, antibody drug conjugate thereof and application thereof 联宁(苏州)生物制药有限公司 2021-12-21 CN disclosed